BVS Stock: Price, Earnings History and SEC Filings
Bioventus Inc. (BVS) last traded at $13.33, down 10.39% on the latest session and down 2.2% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.22 against an analyst estimate of $0.22, a beat of 0.0%.
$13.33 -10.39%
1 month-2.24%
52-week high$15.89
52-week low$6.47
Volume666,689
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
BVS earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 5, 2026 | $0.22 | $0.22 | +0.00% |
| Mar 2026 | May 6, 2026 | $0.15 | $0.09 | +66.67% |
| Dec 2025 | Mar 5, 2026 | $0.24 | $0.22 | +9.09% |
BVS beat the analyst EPS estimate in 2 of its last 3 reported quarters. Source: Nasdaq.
Latest SEC filings for BVS
SEC filing data is not available right now. You can search for BVS on SEC EDGAR.
BVS news
- Bioventus to Report Third Quarter of Fiscal Year 2026 Financial Results on November 2, 2026Oct 27, 2026 · finance.yahoo.com
About Bioventus Inc.
Bioventus Inc. (BVS) is a US-listed public company on Nasdaq.